Abstract
Yoshihito Morimoto, Katsuhiro Kato, Hidenori Yamamoto, Kentaro Suzuki, Kiyotaka Go, Yoshie Fukasawa, Naoki Ohashi, Taichi Kato
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Advances in therapeutic interventions for patients with pulmonary arterial hypertension
10.1161/circulationaha.114.006974 · 2014
Plexiform lesions in pulmonary arterial hypertension: composition, architecture, and microenvironment
10.1016/j.ajpath.2011.03.040 · 2011
A new day has come: Sotatercept for the treatment of pulmonary arterial hypertension
10.1016/j.healun.2024.09.021 · 2025
Laser-capture microdissection
10.1038/nprot.2006.85 · 2006
Combining laser capture microdissection and proteomics: methodologies and clinical applications
10.1002/prca.200900138 · 2010
Mass spectrometry imaging, laser capture microdissection, and LC–MS/MS of the same tissue section
10.1021/acs.jproteome.7b00284 · 2017
Histologic and proteomic remodeling of the pulmonary veins and arteries in a porcine model of chronic pulmonary venous hypertension
10.1093/cvr/cvac005 · 2023
Laser capture microdissection coupled mass spectrometry (LCM-MS) for spatially resolved analysis of formalin-fixed and stained human lung tissues
10.1186/s12014-020-09287-6 · 2020
Proteomic analysis of lung tissues from patients with pulmonary arterial hypertension
10.1161/circulationaha.110.972745 · 2010
Digital spatial profiling identifies distinct molecular signatures of vascular lesions in pulmonary arterial hypertension
10.1164/rccm.202307-1310oc · 2024
Formation of plexiform lesions in experimental severe pulmonary arterial hypertension
10.1161/circulationaha.109.927681 · 2010
Macitentan reverses early obstructive pulmonary vasculopathy in rats: early intervention in overcoming the survivin-mediated resistance to apoptosis
2015
Curing SMA: are we there yet?
10.1038/s41434-022-00349-y · 2023
Potential contribution of phenotypically modulated smooth muscle cells and related inflammation in the development of experimental obstructive pulmonary vasculopathy in rats
10.1371/journal.pone.0118655 · 2015
Proteomic analysis of neurons microdissected from formalin-fixed, paraffin-embedded Alzheimer’s disease brain tissue
10.1038/srep15456 · 2015
Isolation of amyloid plaques and neurofibrillary tangles from archived Alzheimer’s disease tissue using laser-capture microdissection for downstream proteomics
10.1007/978-1-4939-7558-7_18 · 2018
Deubiquitinases as a signaling target of oxidative stress
10.1016/j.celrep.2012.11.011 · 2012
Naked cuticle homolog 1 prevents mouse pulmonary arterial hypertension via inhibition of Wnt/β-catenin and oxidative stress
2023
RNA-binding proteins in pulmonary hypertension
2020
Novel pathological role of hnRNPA1 (heterogeneous nuclear ribonucleoprotein A1) in vascular smooth muscle cell function and neointima hyperplasia
10.1161/atvbaha.117.310020 · 2017
Accurate qualitative and quantitative proteomic analysis of clinical hepatocellular carcinoma using laser capture microdissection coupled with isotope-coded affinity tag and two-dimensional liquid chromatography mass spectrometry
10.1074/mcp.m300133-mcp200 · 2004
Spatially-resolved proteomics: rapid quantitative analysis of laser capture microdissected alveolar tissue samples
10.1038/srep39223 · 2016
Annexin A3 is a potential angiogenic mediator
10.1016/j.bbrc.2005.10.004 · 2005
Critical role of caveolin-1 loss/dysfunction in pulmonary hypertension
2021
Transgelin as a therapeutic target to prevent hypoxic pulmonary hypertension
2014
miR-182-3p/Myadm contribute to pulmonary artery hypertension vascular remodeling via a KLF4/p21-dependent mechanism
10.7150/thno.44687 · 2020
Transforming growth factor β1 increases expression of contractile genes in human pulmonary arterial smooth muscle cells by potentiating sphingosine-1-phosphate signaling
10.1124/molpharm.120.000019 · 2021
Fatty acid-binding protein 5 aggravates pulmonary artery fibrosis in pulmonary hypertension secondary to left heart disease via activating Wnt/β-catenin pathway
10.1016/j.jare.2021.11.011 · 2022
Multiple roles of macrophage migration inhibitory factor in pulmonary hypertension
2019
Peroxiredoxin-2 plays a pivotal role as multimodal cytoprotector in the early phase of pulmonary hypertension
10.1016/j.freeradbiomed.2017.08.004 · 2017
Thymosin beta 4 protects mice from monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy
10.1371/journal.pone.0110598 · 2014
Comparative analyses of the variation of the transcriptome and proteome of Rhodobacter sphaeroides throughout growth
10.1186/s12864-019-5749-3 · 2019
Quantitative proteomic and phosphoproteomic profiling of lung tissues from pulmonary arterial hypertension rat model
10.3390/ijms24119629 · 2023
Using extracellular matrix derived from sugen–chronic hypoxia lung tissue to study pulmonary arterial hypertension
10.3389/fphar.2023.1192798 · 2023
Angiotensin-converting enzyme 2 alleviates pulmonary artery hypertension through inhibition of focal adhesion kinase expression
10.3892/etm.2021.10599 · 2021
Altered airway microbiota composition in patients with pulmonary hypertension
10.1161/hypertensionaha.120.15025 · 2020
Regulation of smooth muscle cell proliferation by NADPH oxidases in pulmonary hypertension
2019
The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension
10.1007/s12016-011-8265-z · 2013
T-type Ca2+ channels elicit pro-proliferative and anti-apoptotic responses through impaired PP2A/Akt1 signaling in PASMCs from patients with pulmonary arterial hypertension
10.1016/j.bbamcr.2017.06.018 · 2017
Proteomic identification of novel differentiation plasma protein markers in hypobaric hypoxia-induced rat model
10.1371/journal.pone.0098027 · 2014
Inhibition of heterogeneous nuclear ribonucleoproteins A1 and oxidative stress reduces glycolysis via pyruvate kinase M2 in chronic thromboembolic pulmonary hypertension
10.2478/jtim-2022-0051 · doi-reference
Identification of microRNA-124 as a major regulator of enhanced endothelial cell glycolysis in pulmonary arterial hypertension via PTBP1 (polypyrimidine tract binding protein) and pyruvate kinase M2
10.1161/circulationaha.117.028034 · doi-reference
Nucleolin regulates pulmonary artery smooth muscle cell proliferation under hypoxia by modulating miRNA expression
10.3390/cells12050817 · doi-reference
HNRNPA2B1: RNA-binding protein that orchestrates smooth muscle cell phenotype in pulmonary arterial hypertension
10.1161/circulationaha.122.059591 · doi-reference
Metabolic and proliferative state of vascular adventitial fibroblasts in pulmonary hypertension is regulated through a microRNA-124/PTBP1 (polypyrimidine tract binding protein 1)/pyruvate kinase muscle axis
10.1161/circulationaha.117.028069 · doi-reference